Blood-based biomarkers for COVID-19

Blood-based biomarkers for COVID-19

June 23, 2020

Establishing biomarkers for COVID-19 that indicate which patients are likely to develop severe disease could help clinicians to categorize patients earlier, improve prognosis and prioritize treatment.
Click here to find out more about Abcam’s SimpleStep ELISA® for blood biomarkers.

Western blot Protocol from Abcam!

Western blot Protocol from Abcam!

Western blotting uses specific antibodies to identify proteins that have been separated based on size by gel electrophoresis. The immunoassay uses a membrane made of nitrocellulose or PVDF (polyvinylidene fluoride). 

April 29, 2019 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us